Impact of Downregulated Inflammation via the IL6R Asp358Ala Variant on Atrial Fibrillation Recurrence Following Ablation.

Kim JA, Kim JJ, Ternes CMP, Chelu MG, Curtis AB

Open source

DOI
10.1016/j.jacadv.2026.103285
Published
2026 Sep 23
Container
JACC. Advances
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacadv.2026.103285,
  title = {Impact of Downregulated Inflammation via the IL6R Asp358Ala Variant on Atrial Fibrillation Recurrence Following Ablation.},
  author = {Kim JA and Kim JJ and Ternes CMP and Chelu MG and Curtis AB},
  year = {2026},
  journal = {JACC. Advances},
  doi = {10.1016/j.jacadv.2026.103285},
  url = {https://doi.org/10.1016/j.jacadv.2026.103285}
}

RIS

TY  - JOUR
TI  - Impact of Downregulated Inflammation via the IL6R Asp358Ala Variant on Atrial Fibrillation Recurrence Following Ablation.
AU  - Kim JA
AU  - Kim JJ
AU  - Ternes CMP
AU  - Chelu MG
AU  - Curtis AB
PY  - 2026
JO  - JACC. Advances
DO  - 10.1016/j.jacadv.2026.103285
UR  - https://doi.org/10.1016/j.jacadv.2026.103285
ER  - 

APA

JA, K., JJ, K., CMP, T., MG, C., & AB, C. (2026). Impact of Downregulated Inflammation via the IL6R Asp358Ala Variant on Atrial Fibrillation Recurrence Following Ablation.. JACC. Advances. https://doi.org/10.1016/j.jacadv.2026.103285

Source records